Bodick Neil

Avg. Two Year Performance

46% Avg. Purchase Return
21% Compound
41% Avg. Sale Return
19% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return17%31%57%6%46%
Purchase Success Rate2 of 21 of 22 of 21 of 21 of 2
Average Sale Return5%15%25%32%41%
Sale Success Rate4 of 74 of 73 of 72 of 77 of 7
Drugs » Drug Manufacturers - Major

Chief Scientific Officer:

Holdings: 489.84K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--